Exosens Shareholder HLD Europe Sells 9.8% Stake To Theon International

Exosens’s shareholder HLD Europe has sold its 9.8% stake in the company to Theon International. This transaction marks a significant change in the ownership structure of Exosens, involving key stakeholders.

Key points of the transaction include:

• HLD Europe’s sale of its entire 9.8% shareholding in Exosens.
• Acquisition of this stake by Theon International, strengthening its position as a major shareholder.
• This change could impact Exosens’s strategic direction and shareholder dynamics going forward.

Further details regarding the terms of the deal, financial considerations, and potential future plans by Theon International have not been disclosed publicly at this time.

About The Author